Event: Pharma Anti-Counterfeiting & Brand Protection Asia

Dates: November 27 – 30, 2012

Venue: TBD, Singapore

Weblink: www.pharmabrandprotection-asia.com

Tel: +65 6508 2401

Email: register@ibcasia.com.sg

 

The cost of a counterfeit drug to a Pharma company includes lost of sales, the daily cost of in-hospital patients and the health cost of mis-diagnosis caused by fake medicines camouflaging genuine symptoms. Monetary factors aside, the most critical factor is the risks to patients' health, and with increasing number of patients displaying resistance to original drugs after consumption of fake versions.

Economic pressures and 'easy' availability through internet channels are encouraging counterfeit drugs.

IBC's inaugural Pharma Anti-Counterfeiting & Brand Protection Asia will bring together the Pharma industry, regulators and enforcers to better understand and learn and implement the latest developments in anti-counterfeiting measures.

Counterfeits have always been prolific in Asia's emerging markets. However, the recent discovery by the US FDA that counterfeit drugs have entered US hospitals and medical centres has made it clear that counterfeiters are becoming more sophisticated, by-passing the most stringent of tests.

This conference and workshops will enable you to weigh strategic risk assessments and calculated costs, to employ strategies to combat counterfeits while protecting your brand.

 

Top 5 Reasons to Attend